Everence Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$399K Hold
2,077
– – 0.02% 490
2026
Q2
$283K Buy
+2,077
New +$255K 0.01% 663
2026
Q1
– Sell
-1,290
Closed -$211K – 875
2025
Q4
$211K Buy
+1,290
New +$202K 0.01% 730
2025
Q2
– Sell
-2,040
Closed -$260K – 837
2025
Q1
$260K Hold
2,040
– – 0.02% 629
2024
Q4
$294K Buy
+2,040
New +$293K 0.02% 587
2019
Q2
– Sell
-5,430
Closed -$321K – 666
2019
Q1
$321K Buy
+5,430
New +$312K 0.06% 384

Other funds holding RGEN

Everence Capital Management's RGEN Position: Q3 2026 in Review

Everence Capital Management held its Repligen (RGEN) position steady in Q3 2026 at 2,077 shares worth $399K. The position accounts for 0.02% of the portfolio, ranked #490.

Everence Capital Management first reported a position in RGEN in Q1 2019 and has held it in 6 quarters since. 341 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • Everence Capital Management held 2,077 shares of Repligen worth $399K as of Q3 2026.
  • Everence Capital Management left its Repligen share count unchanged in Q3 2026.
  • Repligen made up 0.02% of Everence Capital Management's portfolio in Q3 2026, its #490 holding.
  • Everence Capital Management first reported a position in Repligen in Q1 2019 and has held it in 6 quarters since.
  • 341 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Everence Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.